TCP
MDCO

Tourbillon Capital Partners’s Medicines Co MDCO Stock Holding History

Tourbillon Capital Partners’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-200,000
Closed -$5.68M – 101
2014
Q1 		$5.68M Buy
+200,000
New +$6.62M 0.27% 62

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Tourbillon Capital Partners's MDCO Position: Q2 2014 in Review

Tourbillon Capital Partners sold out of Medicines Co (MDCO) in Q2 2014, closing a stake of 200,000 shares — an estimated $5.68M sold.

Tourbillon Capital Partners first reported a position in MDCO in Q1 2014 and held it in 1 quarter. The position peaked at $5.68M in Q1 2014. 152 funds tracked by Wall St. Rank hold MDCO as of Q2 2014.

  • Tourbillon Capital Partners reported no remaining Medicines Co position as of Q2 2014 after selling out during the quarter.
  • Tourbillon Capital Partners sold 200,000 Medicines Co shares in Q2 2014, an estimated $5.68M.
  • Tourbillon Capital Partners first reported a position in Medicines Co in Q1 2014 and held it in 1 quarter.
  • Tourbillon Capital Partners's Medicines Co position peaked at $5.68M in Q1 2014.
  • 152 funds tracked by Wall St. Rank held Medicines Co as of Q2 2014.

Based on Tourbillon Capital Partners's 13F filing for Q2 2014, filed 14 Aug 2014.